A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2002
12/25/2002	CN1387537A Pharmaceutical compositions and methods of using secreted frizzled related protein
12/25/2002	CN1387531A Pyrazolo [4,3-d] pyrimidine derivs.
12/25/2002	CN1387530A Imidazopyridine derivs. used as phosphodiesterase VII inhibitors
12/25/2002	CN1387528A Heterocyclic substd, pyrazolones
12/25/2002	CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor
12/25/2002	CN1387513A Positive modulators of nicotinic receptor agonists
12/25/2002	CN1387512A Positive modulators for nicotinic receptor agonists
12/25/2002	CN1387509A Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity
12/25/2002	CN1387507A Diaryl-enynes
12/25/2002	CN1387440A Methods for treating diabetes
12/25/2002	CN1387434A Synergistic combinations of NK1 receptor antagonist and GABA structural analog
12/25/2002	CN1387433A Method for administering phosphodiesterase 4 inhibitor
12/25/2002	CN1386517A Medicine for treating Parkinson's disease and its preparing process
12/25/2002	CN1386511A Medicine for preventing and treating senile dementia
12/25/2002	CN1386505A Application of Na-ion channel blocker and opium antalgesic in preparing synergic antalgic medicine for mammal
12/25/2002	CN1386504A Combined therapy for melancholia and anxiety
12/25/2002	CN1386503A Combined therapy for treating alcoholism and addiction of alcohol
12/25/2002	CN1097053C 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivs., preparing method and use thereof
12/25/2002	CN1097050C Substd 2,4-imidazolidinedione compounds and pharmaceutical active ingredients
12/25/2002	CN1096858C Gepirone dosage form
12/25/2002	CN1096857C Iontophoretic delivery of antimigraine drug
12/25/2002	CN1096853C Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
12/24/2002	US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity
12/24/2002	US6498243 Epimorphin antagonist and process for producing it
12/24/2002	US6498233 Nucleic acid transfer system
12/24/2002	US6498191 For treatment of alzheimer's disease, diabetes mellitus, parkinson's disease, neuronal and cardiac ischemia, huntington's disease, stroke
12/24/2002	US6498180 Such as 2-(3'-hydroxymethyl-2'-carboxycyclopropyl)glycine; modulating metabotropic glutamate receptor; treating disorders of central nervous
12/24/2002	US6498177 Alpha 2 adrenergic receptor agonist; analgesic, sedative and anaesthetic agents
12/24/2002	US6498168 Muscarinic antagonists
12/24/2002	US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system
12/24/2002	US6498151 Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
12/24/2002	US6498143 Method for assisting in differential diagnosis and treatment of autistic syndromes
12/24/2002	US6497699 Hybrid neuroprosthesis for the treatment of brain disorders
12/24/2002	CA2252039C Isatin derivatives as acetylcholinesterase inhibitors and analgesics
12/24/2002	CA2131019C Nitrosation process
12/24/2002	CA2054339C 3-amidoindolyl derivatives
12/20/2002	WO2002000259A1 Remedial agent for anxiety neurosis or depression and piperazine derivative
12/20/2002	CA2413506A1 Remedial agent for anxiety neurosis or depression and piperazine derivative
12/19/2002	WO2002101392A2 Methods for treating disorders of the nervous and reproductive systems
12/19/2002	WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002	WO2002101045A2 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002	WO2002101009A2 Structural and cytoskeleton-associated proteins
12/19/2002	WO2002101008A2 Intracellular signaling molecules
12/19/2002	WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002	WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/19/2002	WO2002100888A1 Somatostatin-dopamine chimeric analogs
12/19/2002	WO2002100865A1 Benzoxazepine derivatives and their use as ampa receptor stimulators
12/19/2002	WO2002100864A1 Pyrazolopyrazine compound and pharmaceutical use thereof
12/19/2002	WO2002100863A1 Corticotropin releasing factor antagonists
12/19/2002	WO2002100862A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine
12/19/2002	WO2002100861A1 1-(3-phenyloxypropyl)piperidine derivatives
12/19/2002	WO2002100859A1 Pde iv inhibitors
12/19/2002	WO2002100858A2 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors
12/19/2002	WO2002100857A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease
12/19/2002	WO2002100856A1 Macrocycles useful in the treatment of alzheimer's disease
12/19/2002	WO2002100854A1 Lactone formulations and method of use
12/19/2002	WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002	WO2002100848A1 Novel phenylalkyl diamine and amide analogs
12/19/2002	WO2002100843A1 Phenoxazine compounds, the compositions containing them and their medicinal uses
12/19/2002	WO2002100842A1 Sulfonyloxazolamines and their use as 5-ht6 ligands
12/19/2002	WO2002100838A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators
12/19/2002	WO2002100836A2 Compounds, compositions and methods for modulating beta-amyloid production
12/19/2002	WO2002100833A1 Rho KINASE INHIBITORS
12/19/2002	WO2002100830A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002	WO2002100828A2 Process for the production of zaleplon
12/19/2002	WO2002100827A2 Method for increasing the survival of dopamine secreting cells
12/19/2002	WO2002100823A1 New compounds useful in reflux disease
12/19/2002	WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes
12/19/2002	WO2002100820A1 Substituted aminoalcohols useful in treatment of alzheimer's disease
12/19/2002	WO2002100818A2 Aminediols as agents for the treatment of alzheimer's disease
12/19/2002	WO2002100812A1 Carboxylic acid derivative and salt thereof
12/19/2002	WO2002100486A1 Method and apparatus for treating uterine myoma
12/19/2002	WO2002100437A2 Ophthalmic compositions comprising hyaluronic acid
12/19/2002	WO2002100434A1 Treatment of neuropathic pain with n-methyl-d-aspartate (nmda) receptor antagonists
12/19/2002	WO2002100429A1 Combination therapies using vitamin b12 and interferon for treatment of viral, proliferative and inflammatory diseases
12/19/2002	WO2002100428A1 Combination therapies using vitamin b12 and therapeutic agents for treatment of viral, proliferative and inflammatory diseases
12/19/2002	WO2002100416A1 Socs-5 molecules, screening therefore and therapeutic uses thereof
12/19/2002	WO2002100414A1 Arylazo-substituted imidazole for the treatment of stress urinary incontinence
12/19/2002	WO2002100412A2 Stabilized dispersion of phytosterol in oil
12/19/2002	WO2002100411A1 Naphtothiazine positive allosteric ampa receptor modulators (paarm)
12/19/2002	WO2002100410A1 Methods of treating alzheimer's disease
12/19/2002	WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
12/19/2002	WO2002100405A1 Isoquinoline inhibitors of p38
12/19/2002	WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002	WO2002100400A1 Organic nitrate-based compounds for the treatment of vasculopathies
12/19/2002	WO2002100399A1 Macrocycles useful in the treatment of alzheimer's disease
12/19/2002	WO2002100393A1 Compositions for ameliorating attention-deficient/hyperactivity disorder
12/19/2002	WO2002100392A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
12/19/2002	WO2002100386A1 Controlled heat induced rapid delivery of pharmaceuticals from skin depot
12/19/2002	WO2002100382A2 Controlled release dosage forms using acrylic polymer, and process for making the same
12/19/2002	WO2002100377A1 PHARMACEUTICAL FORMULATION FOR THE EFFICIENT ADMINISTRATION OF APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND THEIR DERIVATIVES AND PRO-DRUGS THEREOF
12/19/2002	WO2002100354A2 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
12/19/2002	WO2002100352A2 Nr2b receptor antagonists for the treatment or prevention of migraines
12/19/2002	WO2002100351A2 A method for treating inflammatory diseases by administering a ppar-delta agonist
12/19/2002	WO2002100350A2 Dopamine receptor ligands and therapeutic methods based thereon
12/19/2002	WO2002100347A2 Prodrugs of gaba analogs, compositions and uses thereof
12/19/2002	WO2002100344A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/19/2002	WO2002100341A2 Compounds for the treatment of metabolic disorders
12/19/2002	WO2002100332A2 Isoxazoline compounds having mif antagonist activity
12/19/2002	WO2002100330A2 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES

1 ... 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 ... 1833